EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 91.62 Million EUR | -9.39% |
| 2022 | 101.12 Million EUR | 30.94% |
| 2021 | 77.22 Million EUR | 39.92% |
| 2020 | 55.19 Million EUR | 4.0% |
| 2019 | 53.06 Million EUR | 8.88% |
| 2018 | 48.74 Million EUR | 3.93% |
| 2017 | 46.89 Million EUR | 0.66% |
| 2016 | 46.59 Million EUR | 20.76% |
| 2015 | 38.58 Million EUR | 19.99% |
| 2014 | 32.15 Million EUR | 19.65% |
| 2013 | 26.87 Million EUR | -11.73% |
| 2012 | 30.44 Million EUR | -6.47% |
| 2011 | 32.54 Million EUR | -9.43% |
| 2010 | 35.93 Million EUR | -11.0% |
| 2009 | 40.37 Million EUR | -7.95% |
| 2008 | 43.86 Million EUR | -2.69% |
| 2007 | 45.07 Million EUR | 38.8% |
| 2006 | 32.47 Million EUR | 12.86% |
| 2005 | 28.77 Million EUR | 3.2% |
| 2004 | 27.88 Million EUR | -12.47% |
| 2003 | 31.85 Million EUR | -20.01% |
| 2002 | 39.82 Million EUR | -25.16% |
| 2001 | 53.2 Million EUR | 5.51% |
| 2000 | 50.42 Million EUR | 38.3% |
| 1999 | 36.46 Million EUR | -19.62% |
| 1998 | 45.36 Million EUR | -10.9% |
| 1997 | 50.9 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 82.21 Million EUR | -7.84% |
| 2024 Q1 | 89.16 Million EUR | -2.69% |
| 2023 Q2 | 95.32 Million EUR | -5.4% |
| 2023 FY | 91.62 Million EUR | -9.39% |
| 2023 Q4 | 91.62 Million EUR | -1.76% |
| 2023 Q1 | 100.76 Million USD | -0.35% |
| 2023 Q3 | 93.26 Million EUR | -2.16% |
| 2022 FY | 101.12 Million EUR | 30.94% |
| 2022 Q4 | 101.12 Million EUR | -3.51% |
| 2022 Q2 | 81.29 Million EUR | 6.34% |
| 2022 Q1 | 76.44 Million EUR | -1.01% |
| 2022 Q3 | 104.8 Million EUR | 28.92% |
| 2021 Q1 | 53.29 Million EUR | -3.43% |
| 2021 FY | 77.22 Million EUR | 39.92% |
| 2021 Q2 | 74.62 Million EUR | 40.01% |
| 2021 Q4 | 77.22 Million EUR | 4.8% |
| 2021 Q3 | 73.68 Million EUR | -1.25% |
| 2020 FY | 55.19 Million EUR | 4.0% |
| 2020 Q4 | 55.19 Million EUR | 6.88% |
| 2020 Q1 | 27.35 Million EUR | -48.45% |
| 2020 Q2 | - EUR | -100.0% |
| 2020 Q3 | 51.63 Million EUR | 0.0% |
| 2019 Q1 | 24.96 Million EUR | -48.78% |
| 2019 Q2 | - EUR | -100.0% |
| 2019 FY | 53.06 Million EUR | 8.88% |
| 2019 Q4 | 53.06 Million EUR | 18.09% |
| 2019 Q3 | 44.94 Million EUR | 0.0% |
| 2018 Q2 | 46.67 Million EUR | 85.54% |
| 2018 FY | 48.74 Million EUR | 3.93% |
| 2018 Q1 | 25.15 Million EUR | -46.35% |
| 2018 Q4 | 48.74 Million EUR | 98.53% |
| 2018 Q3 | 24.55 Million EUR | -47.41% |
| 2017 FY | 46.89 Million EUR | 0.66% |
| 2017 Q3 | 25.38 Million EUR | -44.43% |
| 2017 Q4 | 46.89 Million EUR | 84.76% |
| 2017 Q1 | 24.45 Million EUR | -47.52% |
| 2017 Q2 | 45.68 Million EUR | 86.82% |
| 2016 Q2 | 46.69 Million EUR | 41.42% |
| 2016 Q1 | 33.01 Million EUR | -14.42% |
| 2016 FY | 46.59 Million EUR | 20.76% |
| 2016 Q4 | 46.59 Million EUR | 91.28% |
| 2016 Q3 | 24.35 Million EUR | -47.83% |
| 2015 Q3 | 13.38 Million EUR | -60.52% |
| 2015 Q4 | 38.58 Million EUR | 188.28% |
| 2015 Q1 | 15.14 Million EUR | -52.91% |
| 2015 FY | 38.58 Million EUR | 19.99% |
| 2015 Q2 | 33.9 Million EUR | 123.9% |
| 2014 Q1 | 9.28 Million EUR | -65.45% |
| 2014 Q4 | 32.15 Million EUR | 184.98% |
| 2014 FY | 32.15 Million EUR | 19.65% |
| 2014 Q3 | 11.28 Million EUR | -65.37% |
| 2014 Q2 | 32.58 Million EUR | 250.97% |
| 2013 Q2 | 26.93 Million EUR | 230.09% |
| 2013 FY | 26.87 Million EUR | -11.73% |
| 2013 Q4 | 26.87 Million EUR | 171.26% |
| 2013 Q3 | 9.9 Million EUR | -63.22% |
| 2013 Q1 | 8.16 Million EUR | -73.19% |
| 2012 Q3 | 24.83 Million EUR | -19.58% |
| 2012 Q2 | 30.87 Million EUR | 0.0% |
| 2012 FY | 30.44 Million EUR | -6.47% |
| 2012 Q4 | 30.44 Million EUR | 22.6% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | 30.76 Million EUR | 0.0% |
| 2011 Q3 | 25.91 Million EUR | -15.77% |
| 2011 Q4 | 32.54 Million EUR | 25.6% |
| 2011 FY | 32.54 Million EUR | -9.43% |
| 2010 Q2 | 39.36 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 FY | 35.93 Million EUR | -11.0% |
| 2010 Q4 | 35.93 Million EUR | 0.0% |
| 2009 FY | 40.37 Million EUR | -7.95% |
| 2009 Q3 | 29.88 Million EUR | -25.36% |
| 2009 Q1 | 35.39 Million EUR | -19.31% |
| 2009 Q2 | 40.03 Million EUR | 13.12% |
| 2009 Q4 | 40.37 Million EUR | 35.13% |
| 2008 FY | 43.86 Million EUR | -2.69% |
| 2008 Q2 | 39.58 Million EUR | 0.0% |
| 2008 Q3 | 32.09 Million EUR | -18.93% |
| 2008 Q4 | 43.86 Million EUR | 36.67% |
| 2007 Q4 | 45.07 Million EUR | 42.54% |
| 2007 FY | 45.07 Million EUR | 38.8% |
| 2007 Q3 | 31.62 Million EUR | 0.0% |
| 2006 Q1 | - EUR | -100.0% |
| 2006 Q3 | - EUR | -100.0% |
| 2006 Q2 | 28.3 Million EUR | 0.0% |
| 2006 FY | 32.47 Million EUR | 12.86% |
| 2006 Q4 | 32.47 Million EUR | 0.0% |
| 2005 Q2 | 27.63 Million EUR | 0.77% |
| 2005 Q4 | 28.77 Million EUR | 0.0% |
| 2005 Q1 | 27.42 Million EUR | -1.65% |
| 2005 FY | 28.77 Million EUR | 3.2% |
| 2004 Q2 | 28.36 Million EUR | -4.19% |
| 2004 FY | 27.88 Million EUR | -12.47% |
| 2004 Q3 | 27 Million EUR | -4.8% |
| 2004 Q4 | 27.88 Million EUR | 3.26% |
| 2004 Q1 | 29.6 Million EUR | -7.08% |
| 2003 Q2 | 34.02 Million EUR | -4.97% |
| 2003 Q3 | 33.3 Million EUR | -2.12% |
| 2003 Q4 | 31.85 Million EUR | -4.34% |
| 2003 Q1 | 35.8 Million EUR | -10.1% |
| 2003 FY | 31.85 Million EUR | -20.01% |
| 2002 Q2 | 43.82 Million EUR | -4.41% |
| 2002 FY | 39.82 Million EUR | -25.16% |
| 2002 Q3 | 40.73 Million EUR | -7.04% |
| 2002 Q4 | 39.82 Million EUR | -2.24% |
| 2002 Q1 | 45.84 Million EUR | -13.85% |
| 2001 Q3 | 48.39 Million EUR | -17.97% |
| 2001 Q1 | 62.69 Million EUR | 24.32% |
| 2001 Q2 | 58.99 Million EUR | -5.9% |
| 2001 Q4 | 53.2 Million EUR | 9.95% |
| 2001 FY | 53.2 Million EUR | 5.51% |
| 2000 FY | 50.42 Million EUR | 38.3% |
| 2000 Q2 | 32.48 Million EUR | -3.04% |
| 2000 Q3 | 33.32 Million EUR | 2.59% |
| 2000 Q4 | 50.42 Million EUR | 51.34% |
| 2000 Q1 | 33.5 Million EUR | -8.12% |
| 1999 Q4 | 36.46 Million EUR | 0.0% |
| 1999 FY | 36.46 Million EUR | -19.62% |
| 1998 FY | 45.36 Million EUR | -10.9% |
| 1998 Q4 | 45.36 Million EUR | 0.0% |
| 1997 FY | 50.9 Million EUR | 0.0% |
| 1997 Q4 | 50.9 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 805.2 Million USD | 88.621% |
| Nemaura Medical Inc. | 14.56 Million USD | -529.142% |
| NeuroPace, Inc. | 107.65 Million USD | 14.888% |
| LENSAR, Inc. | 69.58 Million USD | -31.671% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 36.13% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -256.165% |
| Apyx Medical Corporation | 79.24 Million USD | -15.628% |
| Cutera, Inc. | 346.29 Million USD | 73.541% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -118.068% |
| BioSig Technologies, Inc. | 1.79 Million USD | -4995.855% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -192.111% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.577% |
| Axonics, Inc. | 719.92 Million USD | 87.273% |
| IRIDEX Corporation | 34.43 Million USD | -166.069% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 77.361% |
| TELA Bio, Inc. | 78.04 Million USD | -17.394% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1643.88% |
| RxSight, Inc. | 182.55 Million USD | 49.809% |
| Align Technology, Inc. | 6.08 Billion USD | 98.494% |
| INVO Bioscience, Inc. | 20.88 Million USD | -338.646% |
| electroCore, Inc. | 16.38 Million USD | -459.123% |
| Telesis Bio, Inc. | 70.41 Million USD | -30.127% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 40.544% |
| Quipt Home Medical Corp. | 247.4 Million USD | 62.967% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 66.145% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -884.14% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -235.986% |
| Dynatronics Corporation | 25.94 Million USD | -253.205% |
| Modular Medical, Inc. | 13.8 Million USD | -563.602% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -754.139% |
| Talis Biomedical Corporation | 98.34 Million USD | 6.83% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2841.125% |
| InMode Ltd. | 863.28 Million USD | 89.387% |
| Envoy Medical, Inc. | 7.64 Million USD | -1099.26% |
| Bruker Corporation | 4.24 Billion USD | 97.844% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1091.153% |
| DexCom, Inc. | 6.26 Billion USD | 98.537% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2422.731% |
| PAVmed Inc | 33.11 Million USD | -176.649% |
| Viveve Medical, Inc. | 25.91 Million USD | -253.581% |
| Cerus Corporation | 197.74 Million USD | 53.667% |
| Movano Inc. | 9.42 Million USD | -872.545% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 81.589% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2422.731% |
| IceCure Medical Ltd | 16.41 Million USD | -458.339% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 90.382% |
| enVVeno Medical Corporation | 48.63 Million USD | -88.39% |
| 908 Devices Inc. | 202.98 Million USD | 54.861% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -114.771% |
| Orthofix Medical Inc. | 925.31 Million USD | 90.098% |
| Surmodics, Inc. | 185.73 Million USD | 50.669% |
| Nuwellis, Inc. | 9.77 Million USD | -837.804% |
| Outset Medical, Inc. | 313.8 Million USD | 70.802% |
| Venus Concept Inc. | 93.65 Million USD | 2.168% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 78.847% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 63.628% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 58.095% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1011.129% |
| Inogen, Inc. | 326.19 Million USD | 71.911% |
| IRadimed Corporation | 92.15 Million USD | 0.578% |
| MaxCyte, Inc. | 268.27 Million USD | 65.847% |
| Pulmonx Corporation | 178.95 Million USD | 48.8% |
| PAVmed Inc. | 33.11 Million USD | -176.649% |
| iCAD, Inc. | 41.41 Million USD | -121.217% |
| OrthoPediatrics Corp. | 449.58 Million USD | 79.62% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -56.191% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -452.647% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1031.529% |
| SI-BONE, Inc. | 230.42 Million USD | 60.237% |
| Semler Scientific, Inc. | 78.06 Million USD | -17.368% |
| Beyond Air, Inc. | 56.96 Million USD | -60.853% |
| FONAR Corporation | 214.24 Million USD | 57.234% |
| AxoGen, Inc. | 196.82 Million USD | 53.45% |
| Biotricity, Inc. | 5.94 Million USD | -1441.801% |
| Cytosorbents Corporation | 53.26 Million USD | -72.029% |
| ZimVie Inc. | 1.2 Billion USD | 92.399% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 67.445% |
| Inari Medical, Inc. | 674.23 Million USD | 86.411% |
| UFP Technologies, Inc. | 404.13 Million USD | 77.329% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -56.191% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -291.577% |
| Sight Sciences, Inc. | 166.65 Million USD | 45.021% |
| Insulet Corporation | 2.58 Billion USD | 96.46% |
| Profound Medical Corp. | 43.68 Million USD | -109.73% |
| Bioventus Inc. | 810.91 Million USD | 88.701% |
| InspireMD, Inc. | 47.64 Million USD | -92.313% |
| BrainsWay Ltd. | 62.97 Million USD | -45.499% |
| BIOLASE, Inc. | 35.1 Million USD | -161.028% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -864.142% |
| Tenon Medical, Inc. | 6.34 Million USD | -1344.026% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -873.993% |
| CVRx, Inc. | 115.22 Million USD | 20.486% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.017% |
| Sintx Technologies, Inc. | 15.36 Million USD | -496.313% |
| Acutus Medical, Inc. | 53.96 Million USD | -69.799% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -753.9% |
| NanoVibronix, Inc. | 6.67 Million USD | -1272.842% |
| Quanterix Corporation | 425.01 Million USD | 78.442% |
| LivaNova PLC | 2.42 Billion USD | 96.229% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 11.601% |
| Varex Imaging Corporation | 1.24 Billion USD | 92.668% |
| Vivani Medical, Inc. | 45.79 Million USD | -100.064% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -884.14% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -70.535% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 94.752% |
| TransMedics Group, Inc. | 706.04 Million USD | 87.023% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -44.992% |
| NeuroMetrix, Inc. | 21.42 Million USD | -327.659% |
| Spectral AI, Inc. | 10.69 Million USD | -756.935% |
| Hyperfine, Inc. | 94.19 Million USD | 2.734% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 65.894% |
| Biomerica, Inc. | 9.25 Million USD | -890.096% |
| Bone Biologics Corporation | 3.73 Million USD | -2351.292% |
| AVITA Medical, Inc. | 144.33 Million USD | 36.522% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1781.953% |
| Silk Road Medical, Inc | 265.3 Million USD | 65.465% |